The 70 kDa S6 kinase: regulation of a kinase with multiple roles in mitogenic signalling

Current Opinion in Cell Biology

Volumn 7, Issue 6, 1995, Pages 806-814

  Chou, Margaret M ^a   Blenis, John ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG BINDING PROTEIN; PHOSPHATIDYLINOSITOL KINASE; PHOSPHOLIPASE C; PHOSPHOTRANSFERASE; RAPAMYCIN;

CELL CYCLE G1 PHASE; DRUG EFFECT; ENZYME PHOSPHORYLATION; ENZYME REGULATION; ENZYME STRUCTURE; MITOGENESIS; MOLECULAR CLONING; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

MITOGENS; PROTEIN-SERINE-THREONINE KINASES; RIBOSOMAL PROTEIN S6 KINASES; SIGNAL TRANSDUCTION; SUPPORT, NON-U.S. GOV'T;

EID: 0028788935     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/0955-0674(95)80064-6     Document Type: Article

References (72)

1. S6k
2. Distinct mechanisms for the activation of the RKS kinases/MAP2 kinase/pp90rsk and pp70 S6 kinase signaling systems are indicated by inhibition of protein synthesis
3. Activation of p70/p85 S6 kinases in interleukin-2-responsive lymphoid cells is mediated by phosphatidylinositol 3-kinase and inhibited by cyclic AMP
4. Interleukin 2 stimulation of p70 S6 kinase is inhibited by the immunosuppressant repamycin
5. Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kD S6 protein kinases
6. Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase
7. Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase
8. Relationship between multiple biological effects of rapamycin and the inhibition of p70 S6 protein kinase activity. Analysis in mutant clones of a T cell lymphoma
9. Dominant missense mutations in a novel yeast protein related to mammalian phosphatidylinositol 3-kinase and VPS34 abrogate rapamycin cytotoxicity
10. TOR1 and TOR2 are structurally and functionally similar but not identical phosphatidylinositol kinase homologues in yeast.
11. Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression
12. A mammalian protein targeted by G1-arresting rapamycin-receptor complex
13. RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORS
14. Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells
15. s6k: functional requirement for entry into S phase
16. S6k function is essential for G1 progression
17. Rapamycin in selectively inhibits translation of mRNAs encoding elongation factors and ribosomal proteins
18. Cloning and expression of two human p70 S6 kinase polypeptides differing only at their amino termini
19. Molecular structure of a major insulin/mitogen-activated 70-kDa S6 protein kinase
20. Differential subcellular localisation of two isoforms of p70 S6 protein kinase
21. S6k is associated with phosphorylation of four clustered sites displaying ser/thr-pro motifs
22. S6k regulation
23. Multiple independent inputs are required for activation of the p70 S6 kinase
24. An array of insulin-activated, proline-directed serine/threonine protein kinases phosphorylate the p70 S6 kinase
25. Phosphatidylinositol 3-kinase
26. S6k activation mediated by phosphatidylinositol-3-OH kinase
27. Phospholipase Cγ1 and phosphatidylinositol 3-kinase are the downstream mediators of the PDGF receptor's mitogenic signal
28. The serine-rich cytoplasmic domain of the interleukin-2 receptor β chain is essential for interleukin-2-dependent tyrosine protein kinase and phosphatidylinositol-3-kinase activation
29. Phosphatidylinositol 3-kinase signals activation of p70 S6 kinase in situ through site-specific p70 phosphorylation
30. Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses
31. Inhibition of histamine secretion by wortmannin through the blockade of phosphatidylinositol 3-kinase in RBL-2H3 cells
32. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002)
33. Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation
34. Insulin receptor substrate-1 mediates phosphatidylinositol 3-kinase and p70 S6k signaling during insulin, insulin-like growth factor-1, and interleukin-4 stimulation
35. Activation of the zeta isozyme of protein kinase C by phosphatidylinositol 3,4,5-trisphosphate
36. 3
37. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase
38. Regulation of human leukocyte p21-activated kinases through G protein-coupled receptors
39. A brain serine/threonine kinase activated by Cdc42 and Rac1
40. Rapamycin sensitivity in Saccharomyces cerevisiae is mediated by a peptidyl-prolyl cis-trans isomerase related to human FK506-binding protein
41. FK506 binding protein 12 mediates sensitivity to both FK506 and rapamycin in murine mast cells
42. Identification of an 11-kDa FKBP12-rapamycin-binding domain within the 289-kDa FKBP12-rapamycin-associated protein and characterization of a critical serine residue
43. TOR kinase domains are required for two distinct functions, only one of which is inhibited by rapamycin
44. Control of p70 S6 kinase by kinase activity of FRAP in vivo
45. S6k through dephosphorylation of a novel set of sites
46. cAMP- and rapamycin-sensitive regulation of the association of eukaryotic initiation factor 4E and the translational regulator PHAS-1 in aortic smooth muscle cells
47. PHAS-1 as a link between mitogen-activated protein kinase and translation initiation
48. Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5'-cap function
49. Positive regulation of the cAMP-responsive activator CREM by the p70 S6 kinase: an alternate route to mitogen-induced gene expression
50. Cross-linking CD28 leads to activation of 70-kDa S6 kinase
51. Function and Activation of NF-kappaB in the Immune System
52. CD28 signaling causes a sustained down-regulation of I kappa B alpha which can be prevented by the immunosuppressant rapamycin.
53. Rapamycin selectively blocks interleukin-2-induced proliferating cell nuclear antigen gene expression in T lymphocytes. Evidence for inhibition of CREB/ATF binding activities
54. Inhibition of cellular proliferation by antisense oligodeoxynucleotides to PCNA cyclin
55. Inhibition of nuclear DNA synthesis by an auto-antibody to proliferating cell nuclear antigen/cyclin
56. Promoter activity of the proliferating-cell nuclear antigen gene is associated with inducible CRE-binding proteins in interleukin 2-stimulated T lymphocytes
57. Mammalian G1 cyclins
58. FKBP-rapamycin inhibits a cyclin-dependent kinase activity and a cyclin D1-cdk association in early G1 of an osteosarcoma cell line
59. cdc2 kinase activation in T lymphocytes
60. Rapamycin blocks cell cycle progression of activated T cells prior to events characteristic of the middle to late G1 phase of the cell cycle
61. KIP1) of cyclin-dependent kinase 4 activation
62. Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin
63. A single Ataxia telangiectasia gene with a product similar to P13-kinase
64. Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin
65. Inhibition of human B lymphocyte cell cycle progression and differentiation by rapamycin
66. The immunosuppressant rapamycin blocks in vitro responses to hematopoietic cytokines and inhibits recovering but not steady state hematopoiesis in vivo
67. Effects of rapamycin on cultured hepatocyte proliferation and gene expression
68. Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells
69. Rapamycin-FKBP12 blocks proliferation, induces differentiation and inhibits cdc2 kinase activity in a myogenic cell line
70. Rapamycin enhances apoptosis and increases sensitivity to cisplatin in vitro
71. Rapamycin selectively represses translation of the ‘polypyrimidine tract’ mRNA family
72. Three distinct IL-2 signaling pathways mediated by bcl-2, myc, and lck cooperate in hematopoietic cell proliferation